Cotton O'neil Clinic Revocable Trust

Cotton O'neil Clinic Revocable Trust was paid $6.84M by Medicaid between Jan 2018 and Dec 2024, across 166 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 14% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Kansas

Rank by total paid#3 of 47

Median peer was paid$64K

This provider vs. median107×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	75,162	$640K
2019	75,955	$654K
2020	75,210	$944K
2021	91,137	$1.42M
2022	90,549	$1.56M
2023	82,049	$1.01M
2024incomplete	62,105	$614K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	14%	15,877	14,955	$960K
80053	Comprehensive metabolic panel	5.9%	57,059	52,909	$406K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	5.7%	10,682	10,386	$389K
84443	Thyroid stimulating hormone (TSH)	5.6%	37,921	36,602	$385K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	5.6%	10,559	10,274	$385K
0240U		5.1%	3,038	2,962	$346K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	3.4%	1,982	1,956	$230K
80061	Lipid panel	3.2%	24,881	24,058	$220K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	3.1%	10,914	10,431	$213K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	3.0%	5,079	4,990	$208K
83036	Hemoglobin; glycosylated (A1C)	3.0%	27,820	27,012	$206K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	2.6%	55,364	49,821	$179K

154 more codes

80081		2.5%	2,129	$168K
86003		1.9%	1,170	$133K
82728		1.6%	8,530	$110K
87086	Culture, bacterial; quantitative colony count, urine	1.6%	14,766	$109K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	1.5%	3,280	$106K
87660		1.5%	5,290	$104K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	1.4%	6,973	$95K
84439		1.4%	12,185	$93K
88142		1.3%	5,555	$92K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	1.3%	4,366	$90K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	1.3%	10,433	$90K
85027		1.0%	11,190	$70K
87081		<1%	9,850	$66K
86803		<1%	5,439	$61K
87077		<1%	8,071	$58K
87480		<1%	5,284	$57K
83655		<1%	5,166	$56K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	1,826	$56K
80048	Basic metabolic panel (calcium, ionized)	<1%	11,119	$54K
87510		<1%	5,288	$53K
82607		<1%	4,959	$51K
87186		<1%	6,341	$49K
83550		<1%	4,955	$41K
84702		<1%	4,567	$41K
81001		<1%	15,070	$38K
84403		<1%	1,466	$32K
87653		<1%	874	$29K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	77	$27K
83540		<1%	6,959	$26K
84153		<1%	2,041	$25K
83970		<1%	1,881	$25K
82784		<1%	1,924	$24K
82570		<1%	5,908	$21K
82950		<1%	3,416	$20K
86140		<1%	4,716	$19K
86038		<1%	1,578	$18K
83001		<1%	865	$17K
84480		<1%	1,312	$17K
82746		<1%	1,601	$17K
84703		<1%	2,006	$16K
87340		<1%	1,719	$16K
83516		<1%	1,610	$15K
83525		<1%	1,400	$14K
84146		<1%	726	$14K
87070		<1%	2,955	$14K
80076		<1%	1,868	$13K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	501	$13K
83735		<1%	3,043	$13K
85651		<1%	3,947	$12K
83002		<1%	571	$12K
83880		<1%	1,013	$12K
82670		<1%	336	$11K
86592		<1%	2,685	$11K
80164		<1%	1,436	$10K
84305		<1%	583	$10K
82947		<1%	2,431	$10K
87205		<1%	2,972	$10K
82105		<1%	888	$10K
86376		<1%	585	$9K
86762		<1%	1,263	$9K
82043		<1%	3,861	$9K
87536		<1%	147	$9K
86850		<1%	1,281	$8K
80074		<1%	296	$8K
84156		<1%	2,544	$8K
82565		<1%	1,965	$7K
84450		<1%	1,735	$6K
84550		<1%	1,891	$6K
84460		<1%	1,474	$6K
83615		<1%	1,316	$6K
82550		<1%	1,276	$6K
86800		<1%	300	$5K
99213	Doctor's office visit, returning patient (routine)	<1%	132	$5K
82533		<1%	333	$5K
85610		<1%	2,063	$4K
86765		<1%	921	$4K
84402		<1%	184	$4K
81003		<1%	5,251	$4K
85045		<1%	1,003	$4K
83690		<1%	795	$4K
82951		<1%	255	$4K
84100		<1%	1,113	$4K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	526	$4K
86780		<1%	297	$3K
87522	Neg quan hep c or qual rna	<1%	452	$3K
86430		<1%	603	$3K
87807		<1%	207	$3K
80069		<1%	603	$3K
84144		<1%	128	$3K
86235		<1%	63	$3K
85044		<1%	519	$2K
86481		<1%	55	$2K
86160		<1%	146	$2K
86901		<1%	621	$2K
99214	Doctor's office visit, returning patient (more involved)	<1%	36	$2K
82977		<1%	389	$2K
85046		<1%	367	$2K
86900		<1%	581	$2K
84425		<1%	105	$2K
86706		<1%	163	$2K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	12	$1K
87210		<1%	322	$1K
86735		<1%	267	$1K
86364		<1%	256	$1K
87147		<1%	215	$1K
87220		<1%	377	$1K
86225		<1%	108	$1K
85652		<1%	606	$1K
86200		<1%	89	$1K
82627		<1%	42	$947.92
80359		<1%	82	$877.73
80346		<1%	81	$870.00
80358		<1%	81	$859.54
80348		<1%	81	$857.95
84155		<1%	482	$857.80
99283	Emergency room visit (moderate)	<1%	30	$845.35
80372		<1%	81	$771.00
80373		<1%	81	$771.00
86308		<1%	110	$698.85
80055		<1%	15	$647.96
82248		<1%	310	$614.71
83721		<1%	142	$609.41
83921		<1%	52	$609.12
81025		<1%	89	$600.33
80177		<1%	68	$532.75
86696		<1%	29	$525.28
83498		<1%	17	$484.82
80324		<1%	80	$446.32
80365		<1%	81	$444.80
80354		<1%	81	$444.80
80361		<1%	81	$442.80
80353		<1%	81	$424.98
84238		<1%	16	$302.85
86704		<1%	20	$267.51
85730		<1%	58	$231.85
80197		<1%	43	$222.72
84165		<1%	50	$220.23
87808		<1%	14	$189.86
86695		<1%	29	$180.29
85018		<1%	172	$150.49
83519		<1%	13	$148.68
84478		<1%	16	$98.79
86787		<1%	12	$92.41
80185		<1%	27	$79.40
85014		<1%	86	$77.28
80156		<1%	14	$76.66
82247		<1%	14	$72.54
36415	Collection of venous blood by venipuncture	<1%	6,116	$38.04
82040		<1%	16	$21.59
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	567	$13.21
83521		<1%	13	$8.81
G0123	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision	<1%	86	$8.56
0100U		0%	27	$0.00
80050	General health panel	0%	98	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKOEHN, KELSEY (ENROLLMENT COORDINATOR)